Pueraria lobata flavone-a natural active substance.
In p>23, Harvard University published the world's first classic monograph on Pueraria. Thirty-one scholars from more than 1 countries in the United States, Europe and Asia systematically studied and expounded the multi-target prevention and treatment effects of Pueraria flavone on coronary arteriosclerosis and cerebral arteriosclerosis caused by human hyperlipidemia, resulting in myocardial ischemia and cerebral ischemia, which caused coronary heart disease, myocardial infarction, cerebral infarction, hemiplegia, vascular dementia and other cardiovascular and cerebrovascular diseases, causing a sensation in the international medical community.
As the only participant in Chinese mainland, the expert R&D team of Xinna Pueraria Flavonoids Soft Capsule participated in the compilation of Pueraria lobata, and systematically studied and expounded the functions of Pueraria lobata Flavonoids (Chapter VII); The effect of pueraria flavonoids on cardiovascular and cerebrovascular diseases (Chapter 8) laid the foundation of pharmacological action of pueraria flavonoids on improving symptoms of myocardial ischemia and cerebral ischemia and preventing and treating cardiovascular and cerebrovascular diseases.
xinna r&d group is the founder of puerarin injection, a natural medicine with independent intellectual property rights in China. it first discovered the pharmacological action and mechanism of puerarin and pueraria flavonoids on ischemic cardiovascular and cerebrovascular diseases in China, which made pueraria lobata, a traditional Chinese medicine, get unprecedented development. Puerarin injection is widely used in clinic, but it can't be used by people in non-clinical and sub-health state. Xinna R&D team invented an innovative process of extracting puerarin by water method. No organic solvent was used in the separation and extraction process, and the purity was greatly improved to over 99.%, ensuring the safety and effectiveness of the product. This process won two national invention patents in succession, and became the first process for the preparation of puerarin injection raw materials and pure pueraria flavonoids in China.